#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13738	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2198	617.9	0	.	n	.	0	A800G	SNP	800	800	A	1034	1034	G	812	G,A	407,386	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13738	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2198	617.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1684	1684	T	716	T,C	678,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13738	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2198	617.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	816	C	792	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25074	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3586	693.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1704	1704	A	798	A	779	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25074	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3586	693.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2338	2338	C	806	C	783	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25074	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3586	693.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2412	2412	A	801	A	785	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25074	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3586	693.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2964	2964	C	714	C,T	694,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25074	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3586	693.6	0	HET	.	.	.	C1644T	.	1644	1644	C	2011	2011	C	806	C,T	607,169	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1860	folP	855	855	100.0	folP.l15.c4.ctg.1	1620	113.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1145	1147	AGC	180;184;183	A;G;C	178;183;179	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5178	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3239	157.9	1	SNP	p	S91F	1	.	.	271	273	TTC	480	482	TTC	180;178;177	T;T;C,T	177;175;174,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5178	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3239	157.9	1	SNP	p	G95N	0	.	.	283	285	GGC	492	494	GGC	167;164;164	G;G;C	164;161;161	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5178	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3239	157.9	1	SNP	p	D95G	1	.	.	283	285	GGC	492	494	GGC	167;164;164	G;G;C	164;161;161	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1774	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1347	130.5	1	SNP	p	G45D	0	.	.	133	135	GGC	408	410	GGC	208;207;207	G;G;C	205;204;203	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	814	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	827	96.1	0	.	n	.	0	A197.	DEL	197	197	A	437	437	A	187	A	183	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4478	parC	2304	2304	99.83	parC.l6.c4.ctg.1	2995	148.5	0	.	p	.	0	G85D	NONSYN	253	255	GGC	631	633	GAC	174;173;173	G;A,G;C	171;166,1;169	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4478	parC	2304	2304	99.83	parC.l6.c4.ctg.1	2995	148.5	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1528	1530	GTC	161;161;162	G;T;C	156;153;154	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4478	parC	2304	2304	99.83	parC.l6.c4.ctg.1	2995	148.5	1	SNP	p	D86N	0	.	.	256	258	GAC	634	636	GAC	174;171;174	G;A;C	171;162;172	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4478	parC	2304	2304	99.83	parC.l6.c4.ctg.1	2995	148.5	1	SNP	p	R87I	0	.	.	259	261	CGT	637	639	CGT	178;180;177	C,A;G;T	175,1;178;173	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4478	parC	2304	2304	99.83	parC.l6.c4.ctg.1	2995	148.5	1	SNP	p	S87R	1	.	.	259	261	CGT	637	639	CGT	178;180;177	C,A;G;T	175,1;178;173	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4478	parC	2304	2304	99.83	parC.l6.c4.ctg.1	2995	148.5	1	SNP	p	R87W	0	.	.	259	261	CGT	637	639	CGT	178;180;177	C,A;G;T	175,1;178;173	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4478	parC	2304	2304	99.83	parC.l6.c4.ctg.1	2995	148.5	1	SNP	p	S88P	0	.	.	262	264	TCC	640	642	TCC	179;184;186	T;C;C	173;180;182	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4002	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2638	150.2	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1355	1357	TGC	177;176;174	T;G;C	170;169;167	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4002	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2638	150.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1565	1567	GGC	215;212;209	G;G;C	207;203;199	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3792	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2324	162.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1228	1230	GCA	212;214;214	G;C;A	206;204;206	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3792	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2324	162.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1231	1233	ATC	213;213;212	A;T;C	207;209;203	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3792	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2324	162.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1243	1245	GTG	214;213;214	G;T;G	211;209;210	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3792	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2324	162.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1243	1245	GTG	214;213;214	G;T;G	211;209;210	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3792	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2324	162.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1747	1749	ACC	152;151;149	A;C;C	146;149;147	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3792	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2324	162.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1801	1803	GCG	136;138;141	G;C,G;G	124;119,2;132	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3792	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2324	162.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1801	1803	GCG	136;138;141	G;C,G;G	124;119,2;132	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3792	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2324	162.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1924	1926	GGC	125;123;121	G;G;C	120;119;115	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3792	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2324	162.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1933	1935	GGC	117;116;115	G;G,A;C	107;110,1;107	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3792	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2324	162.0	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1951	1953	TCG	110;112;108	T,G;C;G	69,12;93;88	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5334	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3053	173.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1613	1615	CCG	180;180;177	C;C,T,G;G,C	161;172,1,1;165,3	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2282	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1703	132.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	554	554	C	162	C	147	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2664	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1748	151.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	550	552	GAA	210;208;209	G;A,C;A	205;203,1;203	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2664	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1748	151.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	838	840	GAT	243;245;248	G,T;A;T	237,1;238;243	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2664	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1748	151.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	961	963	TCA	191;192;195	T;C;A	182;184;188	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2664	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1748	151.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1090	1092	GTC	190;189;190	G;T;C,A	187;184;188,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2664	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1748	151.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1420	1422	GCA	214;215;219	G;C;A	208;205;212	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2664	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1748	151.0	1	SNP	p	G120K	1	.	.	358	360	AAG	796	798	AAG	226;223;226	A;A;G,C	223;221;223,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2664	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1748	151.0	1	SNP	p	A121D	1	.	.	361	363	GAC	799	801	GAC	226;222;223	G;A,C;C	222;216,1;218	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2664	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1748	151.0	1	SNP	p	D121N	0	.	.	361	363	GAC	799	801	GAC	226;222;223	G;A,C;C	222;216,1;218	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9238	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4879	188.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2058	2060	AAT	222;223;227	A,C;A;T	218,1;220;220	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1156	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	982	116.6	1	SNP	p	V57M	1	.	.	169	171	ATG	426	428	ATG	210;210;208	A;T;G	208;207;206	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
